Presentation description

This research explores targeting ceramide metabolism as a potential intervention for Alzheimer's disease. By using both pharmaceutical and genetic approaches in a mouse model, reducing ceramides improves cognitive function and reduces neuroinflammation. The findings highlight ceramide metabolism as a promising therapeutic target for mitigating Alzheimer's disease progression.